Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice

被引:2
|
作者
Huang, Yuzhe [1 ,2 ,3 ,4 ]
Chen, Hao [1 ,4 ]
Chen, Jielin [1 ,4 ]
Wu, Qingxi [1 ,4 ]
Zhang, Wenna [1 ,4 ]
Li, Daxiang [5 ]
Lu, Yongming [1 ,4 ]
Chen, Yan [1 ,4 ]
机构
[1] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China
[2] Anhui Univ Chinese Med, Dept Pharm, Hefei 230012, Anhui, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei 230012, Anhui, Peoples R China
[4] Key Lab Ecol Engn & Biotechnol Anhui Prov, Hefei 230601, Peoples R China
[5] Anhui Agr Univ, Sch Tea & Food Sci, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China
关键词
Yellow tea; Polysaccharies; NAFLD; Targeted metabolomics; Gut microbiota; RECEPTOR;
D O I
10.1016/j.phymed.2024.155919
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear. Purpose: This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice. Methods: The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism. Results: Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers. Conclusions: YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential pro- biotic formulation, offering a feasible dietary intervention for NAFLD.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] A new bile acid treatment for non-alcoholic fatty liver disease
    Chan, Wah Kheong
    Wong, Vincent Wai-Sun
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (10): : 747 - 749
  • [42] Bile Acid Diarrhea Is Associated With Non-Alcoholic Fatty Liver Disease
    Appleby, Richard N.
    Nolan, Jonathan D.
    Johnston, Ian M.
    Pattni, Sanjeev S.
    Fox, Jessica M.
    Walters, Julian R.
    GASTROENTEROLOGY, 2015, 148 (04) : S68 - S69
  • [43] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Luo, Hanyan
    Wu, Hongwei
    Wang, Lixia
    Xiao, Shuiming
    Lu, Yaqi
    Liu, Cong
    Yu, Xiankuo
    Zhang, Xiao
    Wang, Zhuju
    Tang, Liying
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [44] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Hanyan Luo
    Hongwei Wu
    Lixia Wang
    Shuiming Xiao
    Yaqi Lu
    Cong Liu
    Xiankuo Yu
    Xiao Zhang
    Zhuju Wang
    Liying Tang
    Communications Biology, 4
  • [45] Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids
    Sun, QinMei
    Xin, Xin
    An, ZiMing
    Hu, YiYang
    Feng, Qin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [46] Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice
    Sun, Xue
    Duan, Xingping
    Wang, Changyuan
    Liu, Zhihao
    Sun, Pengyuan
    Huo, Xiaokui
    Ma, Xiaodong
    Sun, Huijun
    Liu, Kexin
    Meng, Qiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 806 : 75 - 82
  • [47] Vine tea kombucha ameliorates non-alcoholic fatty liver disease in high-fat diet fed mice via antioxidation, anti-inflammation and regulation of gut microbiota
    Cheng, Jin
    Huang, Si-Yu
    Xiong, Ruo-Gu
    Wu, Si-Xia
    Yang, Zhi-Jun
    Zhou, Dan-Dan
    Saimaiti, Adila
    Zhao, Cai-Ning
    Zhu, Hui-Lian
    Li, Hua-Bin
    FOOD BIOSCIENCE, 2024, 62
  • [48] Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice
    He, Beihui
    Jiang, Jianping
    Shi, Zheng
    Wu, Liyan
    Yan, Junbin
    Chen, Zheng
    Luo, Minmin
    Cui, Dawei
    Xu, Sumei
    Yan, Maoxiang
    Zhang, Shuo
    Chen, Zhiyun
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 135
  • [49] Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice
    Li, Qiong
    Li, Meng
    Li, Fenghua
    Zhou, Wenjun
    Dang, Yanqi
    Zhang, Li
    Ji, Guang
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 258
  • [50] A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis
    Lee, Su-Been
    Gupta, Haripriya
    Min, Byeong-Hyun
    Ganesan, Raja
    Sharma, Satya Priya
    Won, Sung-Min
    Jeong, Jin-Ju
    Cha, Min-Gi
    Kwon, Goo-Hyun
    Jeong, Min-Kyo
    Hyun, Ji-Ye
    Eom, Jung-A
    Park, Hee-Jin
    Yoon, Sang-Jun
    Lee, Sang Youn
    Choi, Mi-Ran
    Kim, Dong Joon
    Oh, Ki-Kwang
    Suk, Ki-Tae
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2024, 52 (01) : 250 - 260